In this edition:

–  Cryoablation vs drug therapy for paroxysmal AF
–  Myopericarditis after COVID-19 mRNA vaccination
–  Rate of progression of aortic stenosis
–  Metformin can be safely used in patients exposed to contrast media
–  Use of bempedoic acid in statin-intolerant patients
–  Effects of dapagliflozin in heart failure patients with or without gout
–  SGLT2 inhibitors and cancer outcomes
–  Overweight or obesity increases the risk of cardiovascular disease
–  Efficacy and safety of the oral PCSK9 inhibitor MK-0616
–  Inflammation and cholesterol as predictors of cardiovascular events in patients taking statins

 

Download Cardiology Research Review, Issue 152, with commentary by A/Prof John Amerena (pdf)